Influence of smoking on vascular reactivity to cGMP generators in human internal thoracic arteries
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Background
There are nitric oxide (NO)-sensitive and -insensitive forms of soluble guanylyl cyclase (sGC). This balance is shifted to the latter under stress conditions associated with increased production of reactive oxygen species (ROS) [1, 2] . The present study investigated whether smoking, a well-documented source of ROS, affects NO-sensitive and -insensitive sGC-mediated effects in human arteries.
Materials and methods
Mechanical responses of internal thoracic arteries obtained from 29 patients undergoing coronary artery bypass grafting were studied. The patients were divided into 2 groups according to their smoking habits: current or ever-smokers (n=17) and former or never-smokers (n=12). Concentration-response curves for nitroglycerin and BAY 60-2770 were constructed in helically-cut strips pre-contracted with phenylephrine, and the values of potency (pD 2 ) were calculated. Relaxations induced by the agonists were presented as relative values to the relaxation caused by 10 -4 M papaverine. Concentrationresponse curves were analyzed using two-way repeated measures analysis of variance and Bonferroni post hoc test. pD 2 values were compared with unpaired two-tailed Student's t-test.
Results
The mean ages of smokers and non-smokers were 70.3 ± 2.1 and 72.3 ± 2.1 years, respectively. The portion of men in smokers (88.2%) was notably higher than that in non-smokers (41.7%). Clinical conditions, laboratory parameters, and medications were similar between the two populations. As shown in Figure 1A , nitroglycerin caused a dose-dependent relaxation, which was not different in the arteries from smokers and nonsmokers. pD 2 values were also identical: 8.03 ± 0.14 (non-smokers) vs. 7.81 ± 0.11 (smokers), p=0.23. Similarly, there was no significant difference in the relaxant potency (pD 2 values, 9.43 ± 0.22 and 9.15 ± 0.14 for non-smokers and smokers, respectively, p=0.26) and efficacy of BAY 60-2770 ( Figure 1B) .
Conclusion
It was demonstrated that smoking is not causal factor for the imbalance between NO-sensitive and -insensitive forms of sGC in human internal thoracic arteries.
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